These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9780052)

  • 1. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression.
    Dykhuizen M; Mitchen JL; Montefiori DC; Thomson J; Acker L; Lardy H; Pauza CD
    J Gen Virol; 1998 Oct; 79 ( Pt 10)():2461-7. PubMed ID: 9780052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.
    Hirsch VM; Santra S; Goldstein S; Plishka R; Buckler-White A; Seth A; Ourmanov I; Brown CR; Engle R; Montefiori D; Glowczwskie J; Kunstman K; Wolinsky S; Letvin NL
    J Virol; 2004 Jan; 78(1):275-84. PubMed ID: 14671109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.
    Nishimura Y; Igarashi T; Buckler-White A; Buckler C; Imamichi H; Goeken RM; Lee WR; Lafont BA; Byrum R; Lane HC; Hirsch VM; Martin MA
    J Virol; 2007 Jan; 81(2):893-902. PubMed ID: 17093193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
    Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
    J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Smith MO; Heyes MP; Lackner AA
    Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
    Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
    J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
    Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
    J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques.
    Villinger F; Switzer WM; Parekh BS; Otten RA; Adams D; Shanmugam V; Bostik P; Mayne AE; Chikkala NF; McClure HM; Novembre F; Yao Q; Heneine W; Folks TM; Ansari AA
    Virology; 2000 Dec; 278(1):194-206. PubMed ID: 11112494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent enhancement of SIV infection: further characterization and cross reactivity between macaque and sooty mangabey isolates.
    Montefiori DC; Robinson WE; Hirsch VM; Modliszewski A; Mitchell WM; Johnson PR
    J Med Primatol; 1990; 19(3-4):269-78. PubMed ID: 2231684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal synthesis of IgG in simian immunodeficiency virus (SIV)-infected rhesus macaques (Macaca mulatta).
    Smith MO; Sutjipto S; Lackner AA
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):81-9. PubMed ID: 8179966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.
    Steger KK; Dykhuizen M; Mitchen JL; Hinds PW; Preuninger BL; Wallace M; Thomson J; Montefiori DC; Lu Y; Pauza CD
    J Virol; 1998 Feb; 72(2):1600-5. PubMed ID: 9445063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.
    Igarashi T; Endo Y; Nishimura Y; Buckler C; Sadjadpour R; Donau OK; Dumaurier MJ; Plishka RJ; Buckler-White A; Martin MA
    J Virol; 2003 Oct; 77(20):10829-40. PubMed ID: 14512533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired responses to Mycobacterium leprae antigens in rhesus monkeys experimentally inoculated with simian immunodeficiency virus and M. leprae.
    Gormus BJ; Murphey-Corb M; Martin LN; Baskin GB; Mack PA; Xu K; Ratteree MS; Gerone PJ; Scollard DM; Gillis TP
    Lepr Rev; 1998 Mar; 69(1):24-39. PubMed ID: 9628093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses.
    Mansfield KG; Westmoreland SV; DeBakker CD; Czajak S; Lackner AA; Desrosiers RC
    J Virol; 1999 Dec; 73(12):10320-8. PubMed ID: 10559350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.
    Letvin NL; King NW
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1023-40. PubMed ID: 2213505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.
    Titanji K; Velu V; Chennareddi L; Vijay-Kumar M; Gewirtz AT; Freeman GJ; Amara RR
    J Clin Invest; 2010 Nov; 120(11):3878-90. PubMed ID: 20972331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.